Xia et al. (52) found that EGCG treatment in a PINK1-mutant Drosophila PD model significantly reduced brain iron accumulation and MDA levels, while increasing SOD and GSH-Px activity, reducing ROS production, and inhibiting iron-dependent cell death. This evidence concerns the gene PINK1 and Parkinson disease.